Syndax Pharmaceuticals Inc (SNDX) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025)

$172.4M

Net Income/Loss (FY2025)

-$285.4M

Total Assets (FY2025)

$529.7M

Total Equity (FY2025)

$64.6M

Cash Flows from Operating Activities (FY2025)

-$323.0M

Source: Syndax Pharmaceuticals Inc 10-K filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.